Home
Conditions
Chickenpox

Clinical trial condition

Chickenpox

Explore clinical trials studying Chickenpox. Study availability and eligibility vary by location and protocol.

137 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Chickenpox trial results

Completed

Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox

NCT00226499

Conditions: Chickenpox, Chickenpox Vaccines, DNA Virus Infections, +5 more
Locations: GSK Investigational Site Brno, Czechia

GSK Investigational Site Chomutov, Czechia

GSK Investigational Site Děčín, Czechia

GSK Investigational Site Havlíčkův Brod, Czechia

View all 104 locations

View Trial Details

Completed

Month 30 & 42 Extension Studies of CRD-004 Primary Study

NCT00492648

Conditions: Chickenpox, DNA Virus Infections, Herpes Zoster, +4 more
Locations: GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years

NCT00802464

Conditions: Chickenpox, DNA Virus Infections, Herpes Zoster, +4 more
Locations: GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Pembroke Pines, Florida, United States

GSK Investigational Site Las Vegas, Nevada, United States

GSK Investigational Site Edison, New Jersey, United States

View Trial Details

Completed

Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age

NCT03114943

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +4 more
Locations: De La Salle Health Sciences Institute Dasmariñas, Cavite, Philippines

View Trial Details

Completed

Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects

NCT00434577

Conditions: Chickenpox, DNA Virus Infections, Herpes Zoster, +4 more
Locations: GSK Investigational Site Hradec Králové, Czechia

GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany

GSK Investigational Site Würzburg, Bavaria, Germany

GSK Investigational Site Hanover, Lower Saxony, Germany

View Trial Details

Completed

Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)

NCT00326183

Conditions: Chickenpox, DNA Virus Infections, Digestive System Diseases, +25 more
Locations: Not specified

View Trial Details

Completed

Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients

NCT00127608

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +4 more
Locations: GSK Investigational Site Prague, Czechia

View Trial Details

Completed

Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates

NCT01519570

Conditions: Chickenpox, DNA Virus Infections, Herpes Zoster Disease, +4 more
Locations: The Ohio State University Martha Morehouse General Internal Medicine Clinic Columbus, Ohio, United States

View Trial Details

Completed

Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056)

NCT00496327

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +4 more
Locations: Not specified

View Trial Details

Completed

Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM).

NCT00792623

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +4 more
Locations: GSK Investigational Site East Melbourne, Victoria, Australia

GSK Investigational Site Melbourne, Victoria, Australia

GSK Investigational Site Melbourne, Victoria, Australia

View Trial Details

Chickenpox

Chickenpox trial results

Related conditions